B.A.D. ETF

B.A.D. ETF

BAD
B.A.D. ETFUS flagNew York Stock Exchange Arca
- -
USD
- -
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChatGPT
Sector
Financial Services
Industry
Asset Management
Address
United States of America
IPO Date
Dec 22, 2021
Business
B.A.D. ETF (NYSE: BAD) is an exchange-traded fund that provides investors with equally-weighted exposure to U.S.-listed large cap companies operating in the betting, alcohol/cannabis, and drugs (pharmaceuticals and biotechnology) market segments by tracking the EQM BAD Index (BADIDX). The fund holds approximately 54 stocks across these thematic areas, including casinos and online gaming operations in betting; alcoholic beverage manufacturing, distribution, cannabis cultivation, and sales in alcohol/cannabis; and pharmaceutical/biotechnology product development and manufacturing in drugs, with key sector allocations to health technology (35%), consumer services (32%), and consumer non-durables (22%). Launched on December 22, 2021, by The BAD Investment Company and listed on the NYSE, the ETF features a 0.75% expense ratio, quarterly rebalancing, and net assets of around $9.5 million as of late 2023, targeting investors seeking contra-ESG or "vice" industry plays with minimal technology exposure. The BAD Investment Company, headquartered in Overland Park, Kansas, serves as the issuer and positions the ETF as a passively managed product offering diversification across resilient sectors tied to human behavior staples, such as gaming expansion, cannabis legalization trends, and pharmaceutical innovation. Geographically, the fund focuses on U.S.-listed companies with primarily domestic operations, though underlying holdings may have global reach in consumer and health markets. No major partnerships, acquisitions, funding rounds, new product launches, or strategic shifts for the B.A.D. ETF or its issuer have been reported in the last 1-2 years as of December 2025; the fund continues to operate with stable holdings and performance amid broader ETF industry consolidation trends.